Mycobacterium ulcerans

(Redirected from M. ulcerans)
Jump to navigation Jump to search
Mycobacterium ulcerans
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. ulcerans
Binomial name
Mycobacterium ulcerans

Buruli ulcer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Buruli ulcer from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycobacterium ulcerans On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycobacterium ulcerans

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycobacterium ulcerans

CDC on Mycobacterium ulcerans

Mycobacterium ulcerans in the news

Blogs on Mycobacterium ulcerans

Directions to Hospitals Treating Buruli ulcer

Risk calculators and risk factors for Mycobacterium ulcerans

This page is about microbiologic aspects of the organism(s).  For clinical aspects of the disease, see Buruli ulcer.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mycobacterium ulcerans (M. ulcerans) is a slow-growing mycobacterium that classically infects the skin and subcutaneous tissues, giving rise to indolent nonulcerated (nodules, plaques) and ulcerated lesions. After tuberculosis and leprosy, Buruli ulcer is the third most common mycobacteriosis of humans. M. ulcerans grows optimally on routine mycobacteriologic media at 33 °C and elaborates a necrotizing immunosuppressive cytotoxin (mycolactone). The bacteria is considered microaerophilic.[1] Large ulcers almost certainly caused by M. ulcerans were first observed by Cook in Uganda in 1897; however, the etiologic agent was not isolated and characterized until 1948 in Australia by MacCallum and associates.[2]

Lesions of M. ulcerans disease have several synonyms (e.g. Bairnsdale or Searle's ulcer). The name Buruli is probably most appropriate for historic reasons, as it is a county of Uganda where important foci of the disease were studied.[3]

Epidemiology and transmission

The source(s) of M. ulcerans in nature is becoming clearer from epidemiologic data and from molecular biologic findings. Because all major endemic foci are in wetlands of tropical or subtropical countries, environmental factors must play an essential role in the survival of the etiologic agent. Koalas and possums are naturally infected animals in Australia. The disease is rarely transmitted from patient to patient. Trauma is probably the most frequent means by which M. ulcerans is introduced into the skin from surface contamination. Individuals of all ages are affected, but the highest frequencies of infection are in children under 15 years of age (Debacker et al. accepted for publication).

Endemic regions and association with water

In many areas, M. ulcerans infection has only occurred after significant environmental disturbance. In the original paper describing the disease, published in 1948, the first patients presented in 1939 in the Bairnsdale District of Victoria, Australia.[2] In December 1935, there had been terrible floods in the district, when all road and rail links had been cut and there had been considerable destruction of property. In Uganda, Barker examined cases of M. ulcerans infection (Buruli ulcer disease) occurring in the Busoga District on the east side of the Victoria Nile, north of Lake Victoria.[4] Although cases were known in the other parts of the country, cases were unknown in the district before 1965. Barker postulated that the outbreak was related to the unprecedented flooding of the lakes of Uganda between 1962 to 1964 as a result of heavy rainfall.

In Nigeria, cases have occurred among Caucasians living on the campus of University of Ibadan only after 1965,[5] when a small stream flowing through the campus was dammed to make artificial lake. The first case reported in Côte d'Ivoire was a French boy of seven years who lived with his parents beside lake Lake Kossou,[6] an artificial lake in the center of the country. In Liberia, cases have been reported in the north of the country[7] following the introduction of swamp rice to replace upland rice. This introduction has been associated with construction of dams on the Mayor river and extended wetlands. In Papua New Guinea, the infection occurs mainly in relation to the Sepik and Kumusi rivers; in the latter areas, the disease is known as the "Kumusi ulcer".[8] The disease occurred after flooding and devastation, which followed the eruption of Mount Lamington in 1951. Reid described how older people living in the villages blamed the volcano for the disease.[8] The recent outbreak of the disease on Philip Island, Victoria,[9] was initially associated with the building of a roadway, inadvertently forming marshlands at the headwaters of an estuary, which was divided by the construction. Again in Australia, the recent increase in the number of cases between 1991 and 1994 in Victoria was associated with the use of recycled waste-water to irrigate a golf course.

A recent visit to Papua New Guinea has not identified any case along the Fly River, that country's largest river, despite significant environmental disturbance due to mining operations in the headwaters. It is clear that other factors must be responsible apart from simple disturbance, one of these must be formation of new water areas where the water is stagnant or only slow moving. A delay between one or three years occurs between the environmental changes and the first patients appearing.

Severe flooding has occurred again in the last few days in the Bairnsdale District of Australia, exceeding the severity of the floods of 1935. It will be interesting to see if this disaster is again followed by increased numbers of patients with M. ulcerans infection.

Seasonal variation

A series of epidemiological studies show the existence of seasonal variation in the appearance of Buruli ulcer cases. It seems that the number of cases augments during dry periods or after inundations.[10][11] These conditions are probably favorable for the development of M. ulcerans, because of the concentration of possible vectors in areas that are frequently visited by humans.

Pathogenesis

The major virulence determinant in M. ulcerans is a polyketide-derived macrolide: mycolactone. Mycolactone was originally isolated from M. ulcerans 1615, a Malaysian isolate, as a mixture of cis/trans isomers designated mycolactone A and mycolactone B. Identical molecules were also found to be present in two M. ulcerans isolates from the Democratic Republic of Congo.[12] More recent evidence shows that M. ulcerans 1615 produces a family of mycolactone congeners which differ primarily in the number of hydroxyl groups and double bonds.[13]

Mycolactone appears to play a key role in the pathogenesis of Buruli ulcer. In vivo studies using a guinea pig model of infection suggest that mycolactone is responsible for both the extensive tissue damage and immunosuppression which accompanies Buruli ulcer.[12] The activity of mycolactone on cultured fibroblasts and macrophage cell lines produces a distinct cytopathic phenotype. The earliest effect is cell rounding, which occurs within 10 h after addition of mycolactone to cultured cells. At 36 h, treated cells are arrested in G1 of the cell cycle, and by 72 h, cells begin to die via apoptosis.[14]

Bacterial macrolides are produced as secondary metabolites by soil bacteria, particularly bacteria such as Streptomyces and Saccharopolyspora species in the order Actinomycetales.[15] Interestingly, a number of related macrolides or congeners are often produced by a single bacterial isolate.[16]

Diagnosis

According to the traditional methods, mycobacteria are preliminarily identified by growth rate and pigmentation.[17] This preliminary grouping may provide presumptive identification of the organism and directs the selection of key biochemical tests to characterize an unknown mycobacterium.[18][19]

Clinical

Because M. ulcerans infection is associated with nonspecific clinical manifestations and indolent course, it is important to consider every nodule or ulcer in an endemic area as a suspected M. ulcerans infection until proven otherwise. A nodule is firm and painless. In the absence of superinfection(s) an ulcer is painless or minimally painful, has the characteristic undermined edge and a whitish-yellow necrotic base. Previous residence in an endemic area should raise the suspicion of M. ulcerans infection.

Laboratory

  • Smears from the necrotic base of ulcers stained by the Ziehl-Neelsen method often reveal clumps of acid-fast bacilli (AFB). Appropriately selected biopsy specimens that include the necrotic base and the undermined edge of lesions with subcutaneous tissue are nearly always diagnostic.
  • M. ulcerans can be cultured from many lesions, either from exudates or tissue fragments, but visible growth often requires 6 to 8 weeks incubation at 33 °C.

Appropriately selected tissue specimen that include necrotic subcutaneous tissue and the undermined edge of ulcerated lesions are frequently diagnostic. Specimens from skin and subcutaneous tissue from nonulcerated lesions are likewise often diagnostic.

Buruli ulcer is often diagnosed late, when treatment can be very difficult and frustrating. Confirmation by culture takes 6–8 weeks. Rapid diagnostic methods for M. ulcerans infection, as well as methods of rapid identification of the organism in clinical and environmental specimens would be a significant advance in the management of M. ulcerans infection. Screening to detect early infection could guide early intervention.

Polymerase chain reaction

There are several polymerase chain reaction PCR methods available that could increase the speed of diagnosis of M. ulcerans infection.[20] PCR is relatively expensive compared to microscopy, and is notorious for producing false-positive results in laboratories that lack experience with PCR. In high-prevalence regions such as West Africa, PCR may not be any more rapid than an accurate clinical case definition combined with a smear that shows acid-fast bacilli. In countries such as Australia, where the incidence is low, the great majority of patients who have nodules, papules or skin ulcers do not have M. ulcerans disease. In this situation, PCR is a quicker way of making the diagnosis with a high degree of confidence. The main advantage of PCR is that M. ulcerans disease can be diagnosed within 24 hours. PCR usefulness for mycobacterial infections is generally limited, however, and at present it is recommended that PCR is used as a rapid ancillary test, not as a replacement for culture and histology.

The PCR method developed by Stinear et al.[21] targets a DNA insertion sequence in M. ulcerans. When genomic M. ulcerans DNA is digested with the restriction enzyme AluI, many 1109 base-pair fragments were obtained. These AluI fragments have been shown to be part of a larger 1293 base-pair repeated sequence that, by chance, happened to contain two AluI restriction sites. The sequence has been named IS2404 (Genbank accession number AF003002)[21][22] It has been recently discovered that IS2404 copies are also present in a large circular plasmid. The total number of IS copies is thus 220. It has been identified in all isolates of M. ulcerans tested to date and has not been found in at least 45 other mycobacterial species, including M. marinum, M. leprae and M. tuberculosis. Recent publications have however demonstrated the presence of IS2404 in M. marinum-like bacteria (Trott et al. accepted for publication).[23]

PCR methods that have been developed are based on the 16S rRNA gene,[24] the hsp65 gene,[25] or the insertion sequence IS2404.[22] In 1999, Guimaraes-Peres et al.[26] evaluated two nested PCRs: the nested IS2404-based PCR and the nested 16S rRNA gene-based PCR. IS2404-based PCR was positive only with M. ulcerans isolates and the closely related M. shinshuense. The 16S rRNA gene-based PCR was positive not only for these two strains but also for M. marinum. The use of IS2404-based PCR as a detection method for M. ulcerans showed better sensitivity and specificity, required less time, and was less costly than the 16S rRNA gene-based PCR.[26]

To date, it has been established that PCR has a specificity of 100% and a sensitivity of 96% compared with culture.

Additionally kits that utilise qPCR detection by probes to confirm the bacterium are as accurate as regular PCR but is quicker, cheaper and requires less skill. Several manufacturers have kits available.[27]

PCR for environmental samples

M. ulcerans belongs to the group of occasional pathogens. Most species belonging to this group are found almost everywhere in nature, and may become pathogenic under special circumstances. Some of them have rarely (e.g. M. malmoense) or never (M. ulcerans) been isolated from the environment. The epidemiological profiles of the diseases they cause, however, suggest that they are present in nature.[28] Recently, M. ulcerans has been detected by molecular biological techniques in water samples collected in Australia[22][29] and in bugs collected from roots of aquatic plants in swamps in endemic regions of Benin and Ghana.[30] M. ulcerans was, however, not recovered by culture from these environmental samples.

PCR is not inhibited by the presence of culturable organisms. Unfortunately, PCR is exquisitely sensitive to inhibition by many compounds such as humic and fulvic acids, which are ubiquitous in the environment and are not removed by standard DNA extraction protocols. The first confirmation that M. ulcerans was present in environmental water samples was obtained in 1997,[31] by combining the highly sensitive and specific IS2404 PCR with a method that separated sample DNA from naturally occurring inhibitors of PCR.

Three different strategies have now been used to overcome inhibition in environmental samples from M. ulcerans endemic regions. The first of these is gel chromatography. Environmental water samples are concentrated and subjected to homogenization with glass beads, followed by heat and alkaline lysis to release DNA. Total extracted DNA is then run through gel chromatography columns that separate DNA from contaminants on the basis of size.[22] Although relatively simple, the method is cumbersome and time-consuming. The second method uses paramagnetic beads linked to M. ulcerans antibodies to capture whole cells and separate them from contaminants in a magnetic field (immunomagnetic separation).[25] Antibodies are raised in laboratory animals. Captured cells are washed to remove inhibitors and then DNA is released by standard methods prior to PCR. The third approach also uses paramagnetic beads, but here the beads are linked to M. ulcerans-specific oligonucleotide probes, which capture IS2404 DNA that has been released from M. ulcerans by homogenization and alkaline lysis. The immobilized DNA is washed to remove inhibitors and used directly as a template for IS2404 PCR. The latter two methods each have limitations and advantages, but offer superior detection sensitivity and are less time-consuming than gel chromatography.

DNA fingerprinting

Molecular typing methods may be categorized into three broad groups on the basis of the type of macromolecules targeted for sub-typing, i.e. methods based on fatty acids, proteins and nucleic acids. Actually, the genotypic typing methods (DNA fingerprinting) that evaluate differences at the DNA level are used more commonly and have emerged as revolutionary tools for epidemiological studies.

The use of DNA fingerprinting for the identification of M. tuberculosis has greatly improved understanding of the epidemiology of tuberculosis: transmission routes of different strains have been recognized;[32] outbreaks of multidrug-resistant strains have been detected early; and the relative importance of reinfection versus reactivation can now be elucidated.[33]

Various molecular methods for fingerprinting of M. ulcerans are now being developed to facilitate studies on the epidemiology of Buruli ulcer. So far, 12 genotypes, spread over the world, have been discriminated, based on a variable number of tandem repeats and mycobacterial interspersed repetitive units. Next-Generation Sequencing will soon dramatically ameliorate subtyping and genotype differentiation.

DNA sequencing

Direct comparison of some genomic DNA sequences of bacterial strains is the best means of quantitatively determining whether two strains are similar or different. Portaels et al. have analyzed the 3’-terminal region of the 16S rRNA gene sequence of 17 strains of M. ulcerans from Africa, Australia and America.[34] This analysis has revealed three subgroups that vary according to the continent of origin. Later, a fourth subgroup was discovered in China and Japan confirming the existence of an Asian type.[35]

Restriction fragment length polymorphism (RFLP)

Insertion sequences (IS) are mobile genetic elements that are usually present in numerous copies within a bacterial genome. These elements can be used as probes, and because the number and location of IS elements vary, each strain will have a unique banding pattern. Molecular analysis of M. ulcerans has revealed two insertion sequences: IS2404 and IS2606.[21] Southern blot analysis to detect IS2404 and IS2606 shows inconclusive RFLP patterns between different strains. Due to the high number of copies of both elements, the banding patterns are difficult to interpret, limiting the value of the Southern blot method to type M. ulcerans isolates.[21]

Jackson et al. have used pTBN12, a well-defined plasmid, as a probe with AluI restriction fragments.[36] The probe was able to distinguish 11 RFLP patterns.

Pulsed field gel electrophoresis (PFGE)

PFGE permits the generation of simplified chromosomal restriction fragment patterns without having to resort to probe hybridization methods. In this method, restriction enzymes that cut DNA infrequently are used to generate large fragments of chromosomal DNA, which are then separated by special electrophoretic procedures. Preliminary results showed that M. ulcerans genomes produce three different profiles according to the three geographical origins of the strains (Type I: Africa, Type II: Australia and Type III: North America) [37]

Amplified fragment length polymorphism (AFLP)

The AFLP technique is based on the selective PCR amplification of restriction fragments from a total digest of genomic DNA.[38] This technique involves three steps: restriction of DNA and ligation of oligonucleotides and adaptors; selective amplification of sets of restriction fragments; and gel analysis of the amplification fragments. Typically 50–100 restriction fragments are amplified and detected on denaturing polyacrylamide gel. AFLP typing results in a clear distinction of M. marinum from M. ulcerans, but interspecies differentiation is not trustworthy[39]

PCR typing methods

PCR is another molecular method that has become increasingly important for epidemiological studies. The technique detects and amplifies small amounts of DNA; 10–100 copies of the templates are enough to perform DNA amplification. Thus, PCR can be used to type organisms that grow slowly on laboratory media, such as M. tuberculosis.[40] PCR also can be used to detect and type pathogens in patients whose culture are negative because they have been treated. Moreover, PCR can be used to amplify the DNA from organisms that are present in tissues preserved in formalin[41] and from non-cultivable organisms (e.g. M. leprae).

Rep-PCR is a modification of the PCR technique that is more suitable for epidemiological purposes than conventional PCR. In this case, the primers are directed towards repetitive chromosomal elements such as IS6110 in M. tuberculosis and the ERIC sequence in other bacteria.[36] In M. ulcerans, the genomic sequence between the IS2404 elements has been amplified. The profiles produced by this technique categorized the strains into three subgroups related to the three different endemic regions (Africa, Australia and North America).

Ribotyping: This method involves amplification of a known sequence cut by restriction enzymes, and compares restriction fragments of amplified DNA from different strains. Using this technique, the M. ulcerans genome has been found to produce three different restriction profiles related to the origin of the strains.

References

  1. ↑ "Buruli ulcer (Mycobacterium ulcerans infection)". Fact Sheet. World Health Organization. July 2014. N°199.
  2. ↑ 2.0 2.1 MacCallum, P., J. C. Tolhurst, G. Buckle, and H. A. Sissons (1948). "A new mycobacterial infection in man. I. Clinical aspects. II. Experimental investigations in laboratory animals. III. Pathology of the experimental lesions in the rat. IV. Cultivation of the new mycobacterium". JPB LX: 93–122.
  3. ↑ Lunn, H. F., D. H. Connor, N. E. Wilks, G. R. Barnley, F. Kamunvi, J. K. Clancey, and J. D. A. Bee (1965). "Buruli (Mycobacterial) ulceration in Uganda. (A new focus of Buruli ulcer in Madi district, Uganda)". East Afr Med J. 42: 275–288. PMID 14341980.
  4. ↑ Barker, D. J. P. (1971). "Buruli disease in a district of Uganda". J Trop Med Hyg. 74 (12): 260–4. PMID 5143865.
  5. ↑ Oluwasanmi, J. O., T. F. Solanke, E. O. Olurin, S. O. Itayemi, G. O. Alabi, and A. O. Lucas (1975). "Mycobacterium ulcerans (Burulli) skin ulceration in Nigeria". Am J Trop Med Hyg. 25 (1): 122–8. PMID 1259075.
  6. ↑ Perraudin, M. L., A. Herrault, and J. C. Desbois (1980). "Ulcère cutané à Mycobacterium ulcerans. (Ulcère de Buruli)". Ann Pediatr. 27: 687–692.
  7. ↑ Ziefer, A., D. H. Connor, and D. W. Gybson (1981). "Mycobacterium ulcerans. Infection of two patients in Liberia". Int J Dermatol. 20 (5): 362–7. doi:10.1111/j.1365-4362.1981.tb00822.x. PMID 7239752.
  8. ↑ 8.0 8.1 Radford, A. J. (1974). "Mycobacterium ulcerans infections in Papua New Guinea". Papua New Guinea Med J. 17: 145–9.
  9. ↑ Johnson, P. D. R., M. G. K. Veitch, P. E. Flood, and J. A. Hayman. (1995). "Mycobacterium ulcerans infection on Phillip Island, Victoria". Med J Aust. 162 (4): 221–2. PMID 7877550.
  10. ↑ Darie, H., T. Le Guyadec, and J. E. Touze (1993). "Aspects épidémiologiques et cliniques de l'ulcère de Buruli en Côte-d'Ivoire". Bull Soc Pathol Exot Filiales. 86: 272–6.
  11. ↑ Portaels, F (1989). "Epidemiologie des ulcères à Mycobacterium ulcerans". Ann Soc Belg Med Trop. 69 (2): 91–103. PMID 2679452.
  12. ↑ 12.0 12.1 George, K. M., D. Chatterjee, G. Gunawardana, D. Welty, J. Hayman, R. Lee, and P. L. C. Small (1999). "Mycolactone: A polyketide toxin from Mycobacterium ulcerans required for virulence". Science. 283 (5403): 854–7. doi:10.1126/science.283.5403.854. PMID 9933171.
  13. ↑ Cadapan, L. D., R. L. Arslanian, J. R. Carney, S. M. Zavala, P. L. Small, and P. Licari (2001). "Suspension cultivation of Mycobacterium ulcerans for the production of mycolactones". FEMS. 205 (2): 385–9. doi:10.1111/j.1574-6968.2001.tb10977.x.
  14. ↑ George, K. M., L. Pascopella, D. M. Welty, and P. L. C. Small (2000). "A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in Guinea pig ulcers and tissue culture cells". Infect Immun. 68 (2): 877–883. doi:10.1128/IAI.68.2.877-883.2000. PMC 97217. PMID 10639458.
  15. ↑ Katz, L. and S. Donadio (1993). "Polyketide synthesis: prospects for hybrid antibiotics". Annu Rev Microbiol. 47: 875–912. doi:10.1146/annurev.mi.47.100193.004303. PMID 8257119.
  16. ↑ Xue, Y., L. Zhao, H. w. Liu, and D. H. Sherman (1998). "A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: Architecture of metabolic diversity". Proceedings of the National Academy of Sciences. 95: 12111–6. doi:10.1073/pnas.95.21.12111.
  17. ↑ Runyon, E. H (1959). "Anonymous mycobacteria in pulmonary disease". Med Clin North Am. 43 (1): 273–290. PMID 13612432.
  18. ↑ Lévy-Frebault, V. V. and F. Portaels (1992). "Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species". Int J Syst Bacteriol. 42 (2): 315–323. doi:10.1099/00207713-42-2-315. PMID 1581193.
  19. ↑ Wayne, L. G., Goodfellow, M., Baess, I., Lind, A., Magnusson, M., Minnikin, D. E., Ridell, M., and Tarnok, I. (1985). "Recommended minimal standards for assigning an organism to the genus Mycobacterium". (Unpublished Work).
  20. ↑ Chemlal, K., G. Huys, P. A. Fonteyne, V. Vincent, A. G. Lopez, L. Rigouts, J. Swings, W. M. Meyers, and F. Portaels (2001). "Evaluation of PCR-restriction profile analysis and IS 2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum". J Clin Microbiol. 39 (9): 3272–8. doi:10.1128/JCM.39.9.3272-3278.2001. PMC 88330. PMID 11526162.
  21. ↑ 21.0 21.1 21.2 21.3 Stinear, T., B. C. Ross, J. K. Davies, L. Marino, R. M. Robins-Brown, F. Oppedisano, A. Sievers, and P. D. R. Johnson (2004). "Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR". J Clin Microbiol. 37 (4): 1018–23. PMC 88643. PMID 10074520.
  22. ↑ 22.0 22.1 22.2 22.3 Ross, B. C., L. Marino, F. Oppedisano, R. Edwards, R. M. Robins-Browne, and D. R. Johnson (1997). "Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection". J Clin Microbiol. 35 (7): 1696–1700. PMC 229824. PMID 9196176.
  23. ↑ Chemlal, K., G. Huys, F. Laval, V. Vincent, C. Savage, C. Gutierrez, M. A. Lanéelle, J. Swings, W. M. Meyers, M. Daffé, and F. Portaels (2002). "Characterization of an unusual Mycobacterium: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans". J Clin Microbiol. 40 (7): 2370–80. doi:10.1128/JCM.40.7.2370-2380.2002. PMC 120612. PMID 12089250.
  24. ↑ Portaels, F., J. Aguiar, K. Fissette, P. A. Fonteyne, H. De Beenhouwer, P. de Rijk, A. Guédénon, R. Lemans, C. Steunou, C. Zinsou, J. M. Dumonceau, and W. M. Meyers (1997). "Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization". J Clin Microbiol. 35 (5): 1097–1100. PMC 232709. PMID 9114387.
  25. ↑ 25.0 25.1 Roberts, B. and R. Hirst. (1997). "Immunomagnetic separation and PCR for detection of Mycobacterium ulcerans". J Clin Microbiol. 35 (10): 2709–11. PMC 230047. PMID 9316944.
  26. ↑ 26.0 26.1 Guimaraes-Peres, A., F. Portaels, P. de Rijk, K. Fissette, S. R. Pattyn, J. P. Van Vooren, and P. A. Fonteyne (1999). "Comparison of two PCRs for detection of Mycobacterium ulcerans". J Clin Microbiol. 37 (1): 206–8. PMC 84208. PMID 9854092.
  27. ↑ http://www.genesig.com/products/9345
  28. ↑ Portaels, F (1995). "Mycobacterial diseases of the skin". New York: Elsevier Clinics in Dermatology: 207–222. |contribution= ignored (help)
  29. ↑ J Med Microbiol; Hirst, RG (1997). "Diagnostic potential of a serological assay for the diagnosis of ulcerans disease based on the putative Mycobacterium ulcerans toxin". Journal of Medical Microbiology. 46 (4): 333–9. doi:10.1099/00222615-46-4-333. PMID 9128198.
  30. ↑ Portaels, F., P. Elsen, A. Guimaraes-Peres, P. A. Fonteyne, and W. M. Meyers (1999). "Insects in the transmission of Mycobacterium ulcerans infection". Lancet. 353 (9157): 986. doi:10.1016/S0140-6736(98)05177-0. PMID 10459918.
  31. ↑ Ross, B. C., P. D. R. Johnson, F. Oppedisano, L. Marino, A. Sievers, T. Stinear, J. A. Hayman, M. G. K. Veitch, and R. M. Robins-Browne (1997). "Detection of Mycobacterium ulcerans in environmental samples during an outbreak of Ulcerative disease". Appl Environ Microbiol. 63 (10): 4135–8. PMC 168730. PMID 9327583.
  32. ↑ van Soolingen, D., P. E. W. De Haas, P. W. M. Hermans, and J. D. A. van Embden (1994). "DNA fingerprinting of Mycobacterium tuberculosis". Methods Enzymol. Methods in Enzymology. 235: 196–205. doi:10.1016/0076-6879(94)35141-4. ISBN 978-0-12-182136-4. PMID 8057895.
  33. ↑ van Soolingen, D., A. G. M. van der Zanden, P. E. W. De Haas, G. T. Noordhoek, A. Kiers, N. A. Foudraine, F. Portaels, A. H. J. Kolk, K. Kremer, and J. D. A. van Embden (1998). "Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers". J Clin Microbiol. 36 (7): 1840–5. PMC 104938. PMID 9650922.
  34. ↑ Portaels, F., P. A. Fonteyne, H. De Beenhouwer, P. de Rijk, A. Guédénon, J. A. Hayman, and W. M. Meyers (1996). "Variability in 3' end of 16S rRNA sequence of Mycobacterium ulcerans is related to geographical origin of isolates". J Clin Microbiol. 34 (4): 962–5. PMC 228926. PMID 8815117.
  35. ↑ Faber, W. R., L. M. Arias-Bouda, J. E. Zeegelaar, A. H. Kolk, P. A. Fonteyne, J. Toonstra, and F. Portaels (2000). "First reported case of Mycobacterium ulcerans infection in a patient from China". Trans R Soc Trop Med Hyg. 94 (3): 277–9. doi:10.1016/S0035-9203(00)90320-1. PMID 10974998.
  36. ↑ 36.0 36.1 Jackson, K. M., R. Edwards, D. E. Leslie, and J. A. Hayman (1995). "Molecular method for typing Mycobacterium ulcerans". J Clin Microbiol. 33 (9): 2250–3. PMC 228388. PMID 7494010.
  37. ↑ WHO (2002). "Buruli ulcer Mycobacterium ulcerans infection". Wkly Epidemiol Rec. 20: 165–6.
  38. ↑ Vos, P., R. Hogers, M. Bleeker, M. Reijans, T. van de Lee, M. Hornes, A. Frijters, J. Pot, J. Peleman, M. Kuiper, and M. Zabeau (1995). "AFLP: a new technique for DNA fingerprinting". Nucleic Acids Res. 23 (21): 4407–4. doi:10.1093/nar/23.21.4407. PMC 307397. PMID 7501463.
  39. ↑ Huys, G., L. Rigouts, K. Chemlal, F. Portaels, and J. Swings (2000). "Evaluation of amplified fragment length polymorphism analysis for inter- and intraspecific differentiation of Mycobacterium bovis, M. tuberculosis, and M. ulcerans". J Clin Microbiol. 38 (10): 3675–80. PMC 87455. PMID 11015382.
  40. ↑ Hance, A. J., B. Grandchamp, V. Vincent-Lévy-Frébault, D. Lecossier, J. Rauzier, D. Bocart, and B. Gicquel (1989). "Detection and identification of mycobacteria by amplification of mycobacterial DNA". Mol Microbiol. 3 (7): 843–9. doi:10.1111/j.1365-2958.1989.tb00233.x. PMID 2507865.
  41. ↑ Versalovic, J., T. Koeuth, and J. R. Lupski (1991). "Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes". Nucleic Acids Res. 19 (24): 6823–31. doi:10.1093/nar/19.24.6823. PMC 329316. PMID 1762913.

External Links

Retrieved from "https://www.wikidoc.org/index.php?title=Mycobacterium_ulcerans&oldid=1129109"